|
|
|
| home > white papers > High Containment FIBCs Offer a Safe and Cost Effective Alternative to their Rigid Counterparts - ILC Dover |
|
|
 WHITE PAPERS |
|
ILC Dover
|
|
High Containment FIBCs Offer a Safe and Cost Effective Alternative to their Rigid Counterparts
|
|
As the need for powder containment and manufacturing in accordance with cGMP standards has grown over the years, companies have sought new alternatives to rigid IBCs. Recently high containment Flexible Intermediate Bulk Containers (FIBCs) have emerged which offer an alternative that provides both powder containment and the benefits of shipping with flexibles.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Northway Biotechpharma enters into Development and Manufacturing Agreement with Synklino
Vilnius, Lithuania, and Copenhagen, Denmark β December 18th 2019 β Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Synklino, a company active in developing a therapeutic protein based therapy as treatment for cytomegalovirus (CMV) infection, announced today that they entered into a Development and Manufacturing Agreement for the recombinant fusion protein SYNx, which Synklino aims to bring into clinical trials.
More info >> |
|
 |
White Papers |
 |
|
Device Develop for Combo Products
Phillips-Medisize
Combination products are defined as therapeutics combining two or more products (drug/device, biologics/device, biologics/drugs or drug/device/biologics), regulated and sold as a single unit. As these pharmaceutical and biological therapies and treatments have evolved, so has the need to develop appropriate delivery mechanisms for these applications. When developing a combination product, there are many things that need to be considered the critical relationships between device development and the pharmaceutical or biologic, early establishment of regulatory and clinical strategies, understanding user needs, determining product requirements, as well as, device manufacturing variation.
More info >> |
|
 |
Industry Events |
 |
Outsourcing in Clinical Trials Europe
26-27 October 2020, Paris, France
Arena International are delighted to announce the return of Outsourcing
in Clinical Trials Europe. Part of our global series of events, this
flagship show will attract the leading clinical professionals from
across Europe. The 10th Annual event will be hosted in Paris.
More info >> |
|
|
|
